Partenaires

Centre National de la recherche scientifique
Logo de l'université de Toulouse Logo de l'Universite Paul Sabatier
Fédération de recherche en biologie de Toulouse



Search

On this website

On the whole CNRS Web


The research at IPBS

The primary objective of the Institute of Pharmacology and Structural Biology, headed by Jean Philippe GIRARD, is the identification and characterization of novel pharmacological targets in the fields of Cancer and Infectious Diseases (Tuberculosis).


News All news

16 June 2016

Symposium of the Fédération de Recherche en Biologie de Toulouse (FRBT) 17 June 2016

Keynote speakers: Jan LÖWE (London) & David RUDNER (Boston) Read more

23 May 2016

Obesity and Cancer: How small vesicles from fat cells can have a big impact on tumor progression

Obesity is, among other complications, associated with the occurrence (...) Read more

6 May 2016

Postdoctoral and PhD positions in Cell Biology & Biophysics

The group "Phagocyte Migration and Differentiation", headed by Dr. (...) Read more

6 May 2016

Postdoctoral position in Bacterial Pathogenesis

A postdoctoral position (2 years) is open in the "Molecular (...) Read more


Seminars

To be noted

Symposium of the Fédération de Recherche en Biologie de Toulouse (FRBT) 17 June 2016

PROGRAMME Fernand Gallais Auditorium, 205 route de Narbonne, Toulouse 10h15 Welcome 10h20 (...)

Press Releases

12 January 2016

Why prostate cancer is more aggressive in obese patients

Obesity has direct consequences on health and is associated with the (...)

Read more

20 October 2015

A new target to fight tuberculosis: a population of immune cells favourable to the resilience of the bacillus

Tuberculosis : An international study conducted by the teams of Drs. (...)

Read more

22 September 2015

How does the kappa opioid receptor recognize its endogenous neuropeptide?

The human kappa opioid receptor (KOR) is implicated in addiction, (...)

Read more

8 September 2015

New clues in the understanding of the DNA repair pathway choice in cells

In response to DNA damage, the choice made by the cells between DNA (...)

Read more